Adenovirus-mediated p16 gene transfer changes the sensitivity to taxanes and vinca alkaloids of human ovarian cancer cells

被引:0
|
作者
Kawakami, Y
Hama, S
Hiura, M
Nogawa, T
Chiba, T
Yokoyama, T
Takashima, S
Tajiri, H
Eguchi, K
Nagai, N
Shigemasa, K
Ohama, K
Kurisu, K
Heike, Y
机构
[1] Natl Shikoku Canc Ctr, Dept Clin Res, Matsuyama, Ehime 7900007, Japan
[2] Natl Shikoku Canc Ctr, Dept Gynecol, Matsuyama, Ehime 7900007, Japan
[3] Hiroshima Univ, Sch Med, Dept Obstet & Gynecol, Minami Ku, Hiroshima 7348551, Japan
[4] Hiroshima Univ, Sch Med, Dept Neurosurg, Minami Ku, Hiroshima 7348551, Japan
关键词
p16; ovarian cancer; growth inhibition; chemoresistance; MAP4;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Deletions and point mutations of the p16 gene are detectable in more than 50% of ovarian cancer cells. In this study, we examined the effect of p16 gene transduction on the growth of ovarian cancer cells and on the effect of anti-cancer agents. Materials and Methods ; p16-null human ovarian cancer cells lines, SKOV-3 and OVCAR-5, were used in this study. We transduced the full-length human p16 gene using recombinant adenovirus (AxCA-hp16). Results: The spontaneous growth of these cells was significantly inhibited by hp16 transduction. MTT assay revealed that AxCA-hp16 infection induced chemoresistance in both cell lines. Flow cytometric analysis revealed that only hp16-transduced SKOV-3, were arrested at the G1-phase for 3 days whereas those infected with AxCA-mock and OVCAR-5 infected with recombinant viruses did not. Western blot analysis showed increased microtubule-association proteins 4 (MAP4) in both cell lines. Conclusion: These results suggest that in SKOV-3 cells, G1-arrest induced by p16-transduction prevents paclitaxel- and vindesine-induced cell death, and in OVCAR-5 cells, the other unknown mechanisms play a role of chemoresistance.
引用
收藏
页码:2537 / 2545
页数:9
相关论文
共 50 条
  • [31] Adenovirus-mediated gene transfer to retinal ganglion cells
    Cayouette, M
    Gravel, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (10) : 2022 - 2028
  • [32] Adenovirus-mediated gene transfer to human cerebral arteries
    Khurana, GV
    Smith, LA
    Weller, DA
    Katusic, ZS
    FASEB JOURNAL, 2000, 14 (08): : A1562 - A1562
  • [33] ADENOVIRUS-MEDIATED GENE-TRANSFER INTO VASCULAR CELLS
    GERARD, RD
    MEIDELL, RS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 314 - 314
  • [34] Adenovirus-mediated gene transfer to human cerebral arteries
    Khurana, VG
    Smith, LA
    Weiler, DA
    Springett, MJ
    Parisi, JE
    Meyer, FB
    Marsh, WR
    O'Brien, T
    Katusic, ZS
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (09): : 1360 - 1371
  • [35] Adenovirus-mediated gene transfer in the treatment of pancreatic cancer
    Pan, X
    Li, ZS
    Xu, GM
    Cui, T
    Tu, ZX
    PANCREAS, 2003, 26 (03) : 274 - 278
  • [36] Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells
    Caroline Craig
    Min Kim
    Ekta Ohri
    Robert Wersto
    Dai Katayose
    Zhuangwu Li
    Yung Hyun Choi
    Bali Mudahar
    Shiv Srivastava
    Prem Seth
    Kenneth Cowan
    Oncogene, 1998, 16 : 265 - 272
  • [37] Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells
    Craig, C
    Kim, M
    Ohri, E
    Wersto, R
    Katayose, D
    Li, ZW
    Choi, YH
    Mudahar, B
    Srivastava, S
    Seth, P
    Cowan, K
    ONCOGENE, 1998, 16 (02) : 265 - 272
  • [38] High efficiency adenovirus-mediated gene transfer to human dendritic cells.
    Dietz, AB
    VukPavlovic, S
    BLOOD, 1997, 90 (10) : 4596 - 4596
  • [39] Adenovirus-mediated gene transfer to human lens epithelial cells in organ culture
    Carrington, LM
    Southgate, T
    Saxby, LA
    Abul-Hassan, K
    Maleniak, TC
    Castro, MG
    Boulton, ME
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2000, 26 (06): : 887 - 892
  • [40] Efficacy of intraperitoneal adenovirus-mediated p53 gene therapy in ovarian cancer
    Von Gruenigen, VE
    O'Boyle, JD
    Coleman, RL
    Wilson, D
    Miller, DS
    Mathis, JM
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1999, 9 (05) : 365 - 372